Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onco Solution
Seoul, Seoul, South Koreaoncosolution.co.kr ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
OncoSolution is a South Korean biotechnology company dedicated to advancing precision oncology through the integration of companion diagnostics (CDx) and targeted therapeutics. The company focuses on developing small molecule inhibitors that target specific genetic drivers of cancer, particularly in non-small cell lung cancer and other solid tumors. By utilizing a proprietary biomarker discovery platform, OncoSolution aims to identify patients most likely to respond to their therapies, thereby increasing clinical success rates. Their current pipeline includes several preclinical candidates designed to overcome resistance mechanisms in existing treatments.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeDiagnostic
- Industry
- Biotech
02
Partnerships
Samsung Medical Center
Beyond the preview
Go deeper on Onco Solution.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Onco Solution.